Copyright Reports & Markets. All rights reserved.

Global GLP-1 Analogues Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global GLP-1 Analogues Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Exenatide
    • 1.3.3 Liraglutide
    • 1.3.4 Semaglutide
    • 1.3.5 Dulaglutide
    • 1.3.6 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global GLP-1 Analogues Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global GLP-1 Analogues Market Size & Forecast
    • 1.5.1 Global GLP-1 Analogues Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global GLP-1 Analogues Sales Quantity (2021-2032)
    • 1.5.3 Global GLP-1 Analogues Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Novo Nordisk
    • 2.1.1 Novo Nordisk Details
    • 2.1.2 Novo Nordisk Major Business
    • 2.1.3 Novo Nordisk GLP-1 Analogues Product and Services
    • 2.1.4 Novo Nordisk GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Novo Nordisk Recent Developments/Updates
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca GLP-1 Analogues Product and Services
    • 2.2.4 AstraZeneca GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AstraZeneca Recent Developments/Updates
  • 2.3 Eli Lily
    • 2.3.1 Eli Lily Details
    • 2.3.2 Eli Lily Major Business
    • 2.3.3 Eli Lily GLP-1 Analogues Product and Services
    • 2.3.4 Eli Lily GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Eli Lily Recent Developments/Updates
  • 2.4 GSK
    • 2.4.1 GSK Details
    • 2.4.2 GSK Major Business
    • 2.4.3 GSK GLP-1 Analogues Product and Services
    • 2.4.4 GSK GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 GSK Recent Developments/Updates
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi GLP-1 Analogues Product and Services
    • 2.5.4 Sanofi GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sanofi Recent Developments/Updates
  • 2.6 Jiangsu Hansoh Pharmaceutical
    • 2.6.1 Jiangsu Hansoh Pharmaceutical Details
    • 2.6.2 Jiangsu Hansoh Pharmaceutical Major Business
    • 2.6.3 Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Product and Services
    • 2.6.4 Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
  • 2.7 Shanghai Benemae Pharmaceutical
    • 2.7.1 Shanghai Benemae Pharmaceutical Details
    • 2.7.2 Shanghai Benemae Pharmaceutical Major Business
    • 2.7.3 Shanghai Benemae Pharmaceutical GLP-1 Analogues Product and Services
    • 2.7.4 Shanghai Benemae Pharmaceutical GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Shanghai Benemae Pharmaceutical Recent Developments/Updates

3 Competitive Environment: GLP-1 Analogues by Manufacturer

  • 3.1 Global GLP-1 Analogues Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global GLP-1 Analogues Revenue by Manufacturer (2021-2026)
  • 3.3 Global GLP-1 Analogues Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of GLP-1 Analogues by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 GLP-1 Analogues Manufacturer Market Share in 2025
    • 3.4.3 Top 6 GLP-1 Analogues Manufacturer Market Share in 2025
  • 3.5 GLP-1 Analogues Market: Overall Company Footprint Analysis
    • 3.5.1 GLP-1 Analogues Market: Region Footprint
    • 3.5.2 GLP-1 Analogues Market: Company Product Type Footprint
    • 3.5.3 GLP-1 Analogues Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global GLP-1 Analogues Market Size by Region
    • 4.1.1 Global GLP-1 Analogues Sales Quantity by Region (2021-2032)
    • 4.1.2 Global GLP-1 Analogues Consumption Value by Region (2021-2032)
    • 4.1.3 Global GLP-1 Analogues Average Price by Region (2021-2032)
  • 4.2 North America GLP-1 Analogues Consumption Value (2021-2032)
  • 4.3 Europe GLP-1 Analogues Consumption Value (2021-2032)
  • 4.4 Asia-Pacific GLP-1 Analogues Consumption Value (2021-2032)
  • 4.5 South America GLP-1 Analogues Consumption Value (2021-2032)
  • 4.6 Middle East & Africa GLP-1 Analogues Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global GLP-1 Analogues Sales Quantity by Type (2021-2032)
  • 5.2 Global GLP-1 Analogues Consumption Value by Type (2021-2032)
  • 5.3 Global GLP-1 Analogues Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global GLP-1 Analogues Sales Quantity by Application (2021-2032)
  • 6.2 Global GLP-1 Analogues Consumption Value by Application (2021-2032)
  • 6.3 Global GLP-1 Analogues Average Price by Application (2021-2032)

7 North America

  • 7.1 North America GLP-1 Analogues Sales Quantity by Type (2021-2032)
  • 7.2 North America GLP-1 Analogues Sales Quantity by Application (2021-2032)
  • 7.3 North America GLP-1 Analogues Market Size by Country
    • 7.3.1 North America GLP-1 Analogues Sales Quantity by Country (2021-2032)
    • 7.3.2 North America GLP-1 Analogues Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe GLP-1 Analogues Sales Quantity by Type (2021-2032)
  • 8.2 Europe GLP-1 Analogues Sales Quantity by Application (2021-2032)
  • 8.3 Europe GLP-1 Analogues Market Size by Country
    • 8.3.1 Europe GLP-1 Analogues Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe GLP-1 Analogues Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific GLP-1 Analogues Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific GLP-1 Analogues Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific GLP-1 Analogues Market Size by Region
    • 9.3.1 Asia-Pacific GLP-1 Analogues Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific GLP-1 Analogues Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America GLP-1 Analogues Sales Quantity by Type (2021-2032)
  • 10.2 South America GLP-1 Analogues Sales Quantity by Application (2021-2032)
  • 10.3 South America GLP-1 Analogues Market Size by Country
    • 10.3.1 South America GLP-1 Analogues Sales Quantity by Country (2021-2032)
    • 10.3.2 South America GLP-1 Analogues Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa GLP-1 Analogues Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa GLP-1 Analogues Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa GLP-1 Analogues Market Size by Country
    • 11.3.1 Middle East & Africa GLP-1 Analogues Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa GLP-1 Analogues Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 GLP-1 Analogues Market Drivers
  • 12.2 GLP-1 Analogues Market Restraints
  • 12.3 GLP-1 Analogues Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of GLP-1 Analogues and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of GLP-1 Analogues
  • 13.3 GLP-1 Analogues Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 GLP-1 Analogues Typical Distributors
  • 14.3 GLP-1 Analogues Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global GLP-1 Analogues market size was valued at US$ 3115 million in 2025 and is forecast to a readjusted size of US$ 4855 million by 2032 with a CAGR of 6.6% during review period.
    GLP-1 analogues are a class of medications used in the treatment of type 2 diabetes. They mimic the effects of glucagon-like peptide 1 (GLP-1), which is a hormone produced by the gut that helps regulate blood sugar levels by stimulating insulin secretion and reducing glucagon secretion.
    This report is a detailed and comprehensive analysis for global GLP-1 Analogues market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global GLP-1 Analogues market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global GLP-1 Analogues market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global GLP-1 Analogues market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global GLP-1 Analogues market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for GLP-1 Analogues
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global GLP-1 Analogues market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Jiangsu Hansoh Pharmaceutical, Shanghai Benemae Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    GLP-1 Analogues market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Exenatide
    Liraglutide
    Semaglutide
    Dulaglutide
    Other
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Novo Nordisk
    AstraZeneca
    Eli Lily
    GSK
    Sanofi
    Jiangsu Hansoh Pharmaceutical
    Shanghai Benemae Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe GLP-1 Analogues product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of GLP-1 Analogues, with price, sales quantity, revenue, and global market share of GLP-1 Analogues from 2021 to 2026.
    Chapter 3, the GLP-1 Analogues competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the GLP-1 Analogues breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and GLP-1 Analogues market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 Analogues.
    Chapter 14 and 15, to describe GLP-1 Analogues sales channel, distributors, customers, research findings and conclusion.

    Buy now